✦ LIBER ✦

Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia

✍ Scribed by Yingmei Zhang; Zhuo Zhang; Jinmei Li; Limin Li; Xueying Han; Lina Han; Longhu Hu; Shuye Wang; Yanhong Zhao; Xiaoxia Li; Ying Zhang; Shengjin Fan; Chengfang Lv; Yinghua Li; Yanhua Su; Hui Zhao; Xin Zhang; Jin Zhou

Book ID: 115554702
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 305 KB
Volume: 119
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27650

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6017 POSTER First line treatment of acut

6017 POSTER First line treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and chemotherapy

✍ Ghavamzadeh, A.; Alimoghaddam, K.; Ghaffari, S.A.; Rostami, S.; Jahani, M.; Irav 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Successful post-remission therapy with a

Successful post-remission therapy with a combination of all-transretinoic acid and arsenic trioxide in an elderly Japanese patient newly diagnosed with acute promyelocytic leukemia

✍ Yujin Kobayashi; Yoshihiro Hatta; Hikari Ishizuka; Yukio Hirabayashi; Toshitake 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 149 KB

Characteristics and prognosis analysis o

Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy

✍ Lou, Yinjun; Suo, Shanshan; Tong, Hongyan; Ye, Xingnong; Wang, Yungui; Chen, Zhi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 886 KB

First-Line Treatment of Newly Diagnosed

First-Line Treatment of Newly Diagnosed Elderly Patients with Chronic Myeloid Leukemia: Current and Emerging Strategies

✍ Gugliotta, Gabriele; Castagnetti, Fausto; Apolinari, Michela; Pirondi, Sara; Cav 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 719 KB

The efficacy and safety of arsenic triox

The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: A meta-analysis

✍ Hao Wang; Xiao-yuan Chen; Bai-song Wang; Zheng-xing Rong; Hong Qi; Hong-zhuan Ch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Treatment of elderly patients (≥60 years

Treatment of elderly patients (≥60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols

✍ Mandelli, F; Latagliata, R; Avvisati, G; Fazi, P; Rodeghiero, F; Leoni, F; Gobbi 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB